Vi-Q-Tuss Interactions
There are 605 drugs known to interact with Vi-Q-Tuss (guaifenesin / hydrocodone), along with 16 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 212 are major, 391 are moderate, and 2 are minor.
- View all 605 medications that may interact with Vi-Q-Tuss
- View Vi-Q-Tuss alcohol/food interactions (1)
- View Vi-Q-Tuss disease interactions (16)
Most frequently checked interactions
View interaction reports for Vi-Q-Tuss (guaifenesin / hydrocodone) and the medicines listed below.
- Abilify (aripiprazole)
- acetaminophen / diphenhydramine
- acetaminophen / hydrocodone
- acetaminophen / propoxyphene
- Advair Diskus (fluticasone / salmeterol)
- Advil PM (diphenhydramine / ibuprofen)
- albuterol
- Aldactone (spironolactone)
- Aleve (naproxen)
- alprazolam
- Ambien CR (zolpidem)
- amitriptyline
- amlodipine
- amoxicillin
- amoxicillin / clavulanate
- aspirin
- Astelin (azelastine nasal)
- atropine / diphenoxylate
- Atuss EX (hydrocodone / potassium guaiacolsulfonate)
- Augmentin (amoxicillin / clavulanate)
- Avinza (morphine)
- baclofen
- Banex-LA (guaifenesin / phenylpropanolamine)
- beclomethasone
- cephalexin
- gabapentin
- Lortab (acetaminophen / hydrocodone)
- metronidazole
- naproxen
- ranitidine
Vi-Q-Tuss alcohol/food interactions
There is 1 alcohol/food interaction with Vi-Q-Tuss (guaifenesin / hydrocodone).
Vi-Q-Tuss disease interactions
There are 16 disease interactions with Vi-Q-Tuss (guaifenesin / hydrocodone) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
Report options
QR code containing a link to this page
More about Vi-Q-Tuss (guaifenesin / hydrocodone)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.